These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34435582)

  • 1. Andrographolide - A prospective remedy for chikungunya fever and viral arthritis.
    Gupta S; Mishra KP; Gupta R; Singh SB
    Int Immunopharmacol; 2021 Oct; 99():108045. PubMed ID: 34435582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Andrographolide Mitigates Unfolded Protein Response Pathway and Apoptosis Involved in Chikungunya Virus Infection.
    Gupta S; Mishra KP; Kumar B; Singh SB; Ganju L
    Comb Chem High Throughput Screen; 2021; 24(6):849-859. PubMed ID: 32819227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of andrographolide against chikungunya virus infection.
    Wintachai P; Kaur P; Lee RC; Ramphan S; Kuadkitkan A; Wikan N; Ubol S; Roytrakul S; Chu JJ; Smith DR
    Sci Rep; 2015 Sep; 5():14179. PubMed ID: 26384169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
    Kaushik S; Dar L; Kaushik S; Yadav JP
    J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection.
    Tran QTN; Lee RCH; Liu HJ; Ran D; Low VZL; To DQ; Chu JJH; Chai CLL
    Eur J Med Chem; 2022 Feb; 230():114110. PubMed ID: 35085859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chikungunya virus infections: time to act, time to treat.
    Abdelnabi R; Neyts J; Delang L
    Curr Opin Virol; 2017 Jun; 24():25-30. PubMed ID: 28414993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under invitro conditions.
    Hasan A; Devi Ms S; Sharma G; Narayanan V; Sathiyarajeswaran P; Vinayak S; Sunil S
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115762. PubMed ID: 36181982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antivirals against the Chikungunya Virus.
    Battisti V; Urban E; Langer T
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographis paniculata (Burm.f.) Nees and its major constituent andrographolide as potential antiviral agents.
    Jiang M; Sheng F; Zhang Z; Ma X; Gao T; Fu C; Li P
    J Ethnopharmacol; 2021 May; 272():113954. PubMed ID: 33610706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demystifying therapeutic potential of medicinal plants against chikungunya virus.
    Kumar S; Garg C; Kaushik S; Buttar HS; Garg M
    Indian J Pharmacol; 2021; 53(5):403-411. PubMed ID: 34854411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transient receptor potential vanilloid 1 (TRPV1) channel regulates chikungunya virus infection in macrophages.
    Sanjai Kumar P; Nayak TK; Mahish C; Sahoo SS; Radhakrishnan A; De S; Datey A; Sahu RP; Goswami C; Chattopadhyay S; Chattopadhyay S
    Arch Virol; 2021 Jan; 166(1):139-155. PubMed ID: 33125586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Members of the
    Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies.
    Wong KZ; Chu JJH
    Viruses; 2018 May; 10(6):. PubMed ID: 29849008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapeutics for chikungunya virus.
    Ghildiyal R; Gabrani R
    Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
    [No Abstract]   [Full Text] [Related]  

  • 15. Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms.
    Ho YJ; Liu FC; Yeh CT; Yang CM; Lin CC; Lin TY; Hsieh PS; Hu MK; Gong Z; Lu JW
    Antiviral Res; 2018 Nov; 159():134-142. PubMed ID: 30300716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
    J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Strategies Against Chikungunya Virus.
    Abdelnabi R; Neyts J; Delang L
    Methods Mol Biol; 2016; 1426():243-53. PubMed ID: 27233277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivirals against Chikungunya Virus: Is the Solution in Nature?
    Martins DOS; Santos IA; de Oliveira DM; Grosche VR; Jardim ACG
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.